Study guide

3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics

EDAIC Part I European Diploma in Anaesthesiology and Intensive Care

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The EDAIC Part I Examination

1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy

2 Chapter 2: Anatomy for Anaesthesia and Intensive Care

2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart

3 Chapter 3: Respiratory and Cardiovascular Physiology

3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics

4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology

4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach

5 Chapter 5: Endocrine and Haematological Physiology

5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders

6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric

6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation

7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics

7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity

8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics

8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents

9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics

9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy

10 Chapter 10: Haematological and Internal Medicine Pharmacology

10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions

11 Chapter 11: Physics, Clinical Measurement and Medical Equipment

11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring

12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis

12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units

13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal

13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)

14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management

14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting

15 Chapter 15: Coexisting Disease and Preoperative Investigations

15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease

16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia

16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury

17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia

17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia

18 Chapter 18: Anaesthetic Complications and Specialty Settings

18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery

19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management

19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management

20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support

20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination

21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes

21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate

22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies

22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure

23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics

23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration

24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies

24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy

25 Chapter 25: Burns, Environmental Emergencies and Patient Transport

25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill

3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics

Key Takeaways Explain This Topic AI

Systemic Vascular Resistance ( S V R = M A P − C V P C O × 80 SVR = \frac{MAP - CVP}{CO} \times 80 S V R = CO M A P − C V P ​ × 80 , normal 800–1200 dynes·s· cm − 5 \text{cm}^{-5} cm − 5 ) and Pulmonary Vascular Resistance ( P V R = M P A P − P A W P C O × 80 PVR = \frac{MPAP - PAWP}{CO} \times 80 P V R = CO MP A P − P A W P ​ × 80 , normal 100–200 dynes·s· cm − 5 \text{cm}^{-5} cm − 5 ) quantify downstream resistance; PVR is approximately one-sixth to one-tenth of SVR and is minimized at Functional Residual Capacity.

Arterial pulse pressure amplifies from the central aorta to peripheral radial and pedal arteries (systolic pressure increases, diastolic pressure decreases) due to progressive reductions in vessel caliber, increased wall stiffness, and constructive summation of reflected pressure waves.

Venous return is driven by the pressure gradient between Mean Systemic Filling Pressure and central venous pressure ( V R = M S F P − C V P R v r VR = \frac{MSFP - CVP}{R_{vr}} V R = R v r ​ MSFP − C V P ​ ); positive pressure ventilation increases intrathoracic pressure, elevating CVP, reducing the driving gradient, and acutely impairing RV filling.

The revised endothelial glycocalyx model demonstrates that continuous capillaries filter fluid along their entire length without steady-state venous reabsorption; filtered fluid and macromolecules are returned exclusively by lymphatic drainage, with filtration governed by the subglycocalyx oncotic gradient ( J v = K f [ ( P c − P i f ) − σ ( π c − π s g ) ] J_v = K_f [(P_c - P_{if}) - \sigma (\pi_c - \pi_{sg})] J v ​ = K f ​ [( P c ​ − P i f ​ ) − σ ( π c ​ − π s g ​ )] ).

Last updated: October 2026

3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics

Systemic hemodynamics and microcirculatory fluid exchange govern organ perfusion and tissue oxygenation. This section examines vascular resistance equations, arterial pulse contour analysis, venous return mechanics, the revised endothelial glycocalyx model, autoregulation, and cardiovascular autonomic reflexes.

1. Systemic and Pulmonary Vascular Resistance and Blood Pressure Determinants

Applying the hydraulic analogue of Ohm's Law ( Δ P = Q × R \Delta P = Q \times R Δ P = Q × R ), vascular resistance represents the ratio of the pressure gradient across a vascular bed to the volumetric flow rate (cardiac output):

  • Systemic Vascular Resistance (SVR)
  • S V R = M A P − C V P C O × 80 SVR = \frac{MAP - CVP}{CO} \times 80 S V R = CO M A P − C V P ​ × 80

M A P MAP M A P : Mean Arterial Pressure ( mmHg \text{mmHg} mmHg ).

C V P CVP C V P : Central Venous Pressure / Right Atrial Pressure ( mmHg \text{mmHg} mmHg ).

C O CO CO : Cardiac Output ( L/min \text{L/min} L/min ).

Conversion Factor ( 80 80 80 ): Converts mmHg ⋅ min / L \text{mmHg} \cdot \text{min} / \text{L} mmHg ⋅ min / L to absolute metric units of dynes ⋅ s ⋅ cm − 5 \text{dynes} \cdot \text{s} \cdot \text{cm}^{-5} dynes ⋅ s ⋅ cm − 5 .

Normal Value: 800 − 1200 dynes ⋅ s ⋅ cm − 5 800-1200\text{ dynes}\cdot\text{s}\cdot\text{cm}^{-5} 800 − 1200 dynes ⋅ s ⋅ cm − 5 (or 10 − 15 Wood units 10-15\text{ Wood units} 10 − 15 Wood units ; 1 Wood unit = 80 dynes ⋅ s ⋅ cm − 5 1\text{ Wood unit} = 80\text{ dynes}\cdot\text{s}\cdot\text{cm}^{-5} 1 Wood unit = 80 dynes ⋅ s ⋅ cm − 5 ).

Arterioles (diameter 10 − 100 μ m 10-100\,\mu\text{m} 10 − 100 μ m ) are the primary site of systemic vascular resistance, responsible for ≈ 60 % \approx 60\% ≈ 60% of total SVR, modulated by vascular smooth muscle tone.

  • Pulmonary Vascular Resistance (PVR)
  • P V R = M P A P − P A W P C O × 80 PVR = \frac{MPAP - PAWP}{CO} \times 80 P V R = CO MP A P − P A W P ​ × 80

M P A P MPAP MP A P : Mean Pulmonary Arterial Pressure ( mmHg \text{mmHg} mmHg ).

P A W P PAWP P A W P : Pulmonary Artery Wedge Pressure / Left Atrial Pressure ( mmHg \text{mmHg} mmHg ).

Normal Value: 100 − 200 dynes ⋅ s ⋅ cm − 5 100-200\text{ dynes}\cdot\text{s}\cdot\text{cm}^{-5} 100 − 200 dynes ⋅ s ⋅ cm − 5 (or 1.2 − 2.5 Wood units 1.2-2.5\text{ Wood units} 1.2 − 2.5 Wood units ). PVR is roughly one-sixth to one-tenth of SVR. Pulmonary Vascular

  • Resistance (PVR)
  • ^
  • | \ / High Volume: Alveolar vessels
  • | \ / stretched and compressed
  • | \ PVR Nadir at FRC /
  • | \ | /
  • | \_____________v_____________/
  • | Low Volume: Extra-alveolar
  • | vessels compressed by lack
  • | of radial tethering
  • +-----------------------------------------> Lung Volume (RV to TLC)
  • RV FRC TLC

The U-Shaped PVR Curve: PVR varies non-linearly with lung volumes:

At High Lung Volumes ( > FRC >\text{FRC} > FRC toward TLC): Alveoli expand and stretch, mechanically compressing small intra-alveolar capillaries, increasing capillary resistance.

At Low Lung Volumes ( < FRC <\text{FRC} < FRC toward RV): Loss of radial elastic parenchymal traction causes larger extra-alveolar conduit vessels to narrow and collapse, increasing resistance.

PVR is minimal at FRC: Mechanical ventilation titrated to maintain lung volumes near normal FRC minimizes RV afterload.

Determinants of Arterial Blood Pressure

Mean Arterial Pressure (MAP): The time-weighted average pressure driving systemic tissue perfusion. At normal resting heart rates ( 60 − 80 bpm 60-80\text{ bpm} 60 − 80 bpm ), diastole comprises two-thirds of the cardiac cycle: M A P = D B P + 1 3 ( S B P − D B P ) MAP = DBP + \frac{1}{3}(SBP - DBP) M A P = D BP + 3 1 ​ ( SBP − D BP ) At significant tachycardia ( > 100 bpm >100\text{ bpm} > 100 bpm ), systole and diastole approach equal duration: M A P ≈ D B P + 1 2 ( S B P − D B P ) MAP \approx DBP + \frac{1}{2}(SBP - DBP) M A P ≈ D BP + 2 1 ​ ( SBP − D BP )

Hemodynamic Determinants: Rearranging Ohm's Law demonstrates that arterial pressure depends on cardiac output, vascular tone, and venous pressure: M A P = ( C O × S V R ) + C V P MAP = (CO \times SVR) + CVP M A P = ( CO × S V R ) + C V P

Pulse Pressure ( P P PP PP ): The difference between systolic and diastolic pressure ( P P = S B P − D B P PP = SBP - DBP PP = SBP − D BP ). Governed directly by ventricular stroke volume and inversely by arterial compliance: P P ≈ S V C art PP \approx \frac{SV}{C_{\text{art}}} PP ≈ C art ​ S V ​

2. Pulse Pressure and Peripheral Arterial Wave Amplification

As the arterial pressure pulse propagates away from the ascending aorta toward peripheral conduit arteries (such as the radial, femoral, and dorsalis pedis arteries), the contour of the arterial waveform changes dramatically: Pressure

  • (mmHg) AORTIC ROOT WAVEFORM RADIAL ARTERY WAVEFORM
  • 140 ^ /\ Elevated SBP
  • | / \ (Amplification)
  • 120 | /\ SBP / \
  • | / \ / \
  • 100 | / \___ / \_ Dicrotic Notch
  • | / | \ (Dicrotic Notch) / | (Delayed/Smoothed)
  • 80 | ----/------+----\--------------------/----------+-------------------
  • | / \ DBP / \ Depressed DBP
  • +-------------------------> Time +-------------------------> Time
  • [ MAP ~ 93 mmHg; Narrow PP ] [ MAP ~ 92 mmHg; Wide PP ]
  • Peripheral Changes and Mechanisms

Systolic Blood Pressure (SBP): Increases progressively (radial artery SBP is often 10 − 20 mmHg 10-20\text{ mmHg} 10 − 20 mmHg higher, and dorsalis pedis SBP up to 20 − 40 mmHg 20-40\text{ mmHg} 20 − 40 mmHg higher than aortic SBP).

Diastolic Blood Pressure (DBP): Decreases progressively.

Pulse Pressure ( P P PP PP ): Widens substantially in peripheral arteries.

Mean Arterial Pressure (MAP): Remains nearly constant, decreasing only slightly ( 1 − 2 mmHg 1-2\text{ mmHg} 1 − 2 mmHg ) due to viscous energy dissipation in large conduit arteries.

Dicrotic Notch: Becomes delayed, smoothed, and less distinct peripherally.

Physical Mechanisms of Peripheral Amplification

Reduced Arterial Caliber: Peripheral arteries are smaller in cross-sectional diameter.

Decreased Vascular Compliance (Increased Stiffness): The central aorta contains abundant distensible elastin fibers, dampening pressure peaks (Windkessel effect). Peripheral muscular arteries contain higher collagen-to-elastin ratios, making them substantially stiffer.

Wave Reflection: When the forward (incident) pressure wave hits downstream high-resistance arteriolar branching points, reflection waves travel backward toward the heart. In peripheral vessels, reflected waves summate constructively with the forward incident wave during systole, augmenting the systolic peak.

Clinical Significance: Peripheral non-invasive or intra-arterial radial cuffs overestimate central aortic systolic pressure and underestimate central diastolic pressure, but accurately track central MAP.

3. Venous Return Mechanics and Cardiopulmonary Interactions

Arthur Guyton established that cardiac output is ultimately governed by the ability of the systemic vasculature to deliver blood back to the right atrium (Venous Return, V R VR V R ). Under steady-state conditions, cardiac output must equal venous return ( C O = V R CO = VR CO = V R ). Flow (L/min)

  • 10 ^ Cardiac Function Curve (Starling)
  • | /---
  • | /--
  • 5 | OPERATING /--
  • | POINT * \ Venous Return Curve
  • | / \
  • | / \
  • 0 +-------------------------+------------+---------> RAP / CVP (mmHg)
  • 0 2 8 (MSFP)
  • Mean Systemic Filling Pressure ( M S F P MSFP MSFP )

Definition: The equilibrium pressure that would exist throughout the entire systemic circulation if cardiac output were instantaneously arrested and blood redistributed uniformly.

Normal Value: ≈ 7 − 10 mmHg \approx 7-10\text{ mmHg} ≈ 7 − 10 mmHg .

Determinants:

Stressed Blood Volume: The fraction of circulating blood volume ( ≈ 30 % \approx 30\% ≈ 30% ) that actively stretches vascular walls beyond their unstressed capacity. (The unstressed volume, ≈ 70 % \approx 70\% ≈ 70% , merely fills the vascular bed without exerting transmural pressure).

Venomotor Tone: Sympathetic venoconstriction shifts blood from the unstressed into the stressed volume compartment, acutely increasing M S F P MSFP MSFP .

The Venous Return Equation

Venous return is driven by the pressure gradient between the peripheral microcirculation ( M S F P MSFP MSFP ) and the right atrium ( R A P RAP R A P , clinically indexed as C V P CVP C V P ):

V R = M S F P − C V P R v r VR = \frac{MSFP - CVP}{R_{vr}} V R = R v r ​ MSFP − C V P ​

Where R v r R_{vr} R v r ​ is the resistance to venous return (determined primarily by venous and venular caliber).

Driving Gradient for Venous Return: Under normal conditions, M S F P − C V P ≈ 8 − 2 = 6 mmHg MSFP - CVP \approx 8 - 2 = 6\text{ mmHg} MSFP − C V P ≈ 8 − 2 = 6 mmHg . Because resistance to venous flow is exceptionally low, this tiny pressure head is sufficient to drive the entire resting cardiac output ( 5 L/min 5\text{ L/min} 5 L/min ).

Impact of Positive Pressure Ventilation on Venous Return

Mechanical ventilation dramatically influences right and left ventricular hemodynamics through cyclic changes in intrathoracic pressure (ITP):

Inspiratory Phase: Positive pressure gas delivery elevates intrathoracic pressure.

Reduction in RV Preload: Elevated ITP is transmitted directly to the right atrium, elevating C V P CVP C V P . This narrows the upstream pressure gradient driving venous return ( M S F P − C V P MSFP - CVP MSFP − C V P ), acutely reducing venous return and right ventricular end-diastolic volume ( E D V EDV E D V ).

Transient Augmentation of LV Preload: Concurrently, positive alveolar pressure compresses pulmonary capillaries, squeezing blood into the left atrium and transiently augmenting LV preload.

Expiratory Phase: Two to three heartbeats later, the reduced RV stroke volume traverses the pulmonary vasculature, resulting in diminished LV filling, decreased LV stroke volume, and a decline in systolic blood pressure.

Dynamic Predictors of Fluid Responsiveness: In mechanically ventilated patients without spontaneous breathing efforts or cardiac arrhythmias, cyclic swings in stroke volume (Stroke Volume Variation, S V V > 12 − 13 % SVV > 12-13\% S VV > 12 − 13% ) and arterial pulse pressure (Pulse Pressure Variation, P P V > 13 % PPV > 13\% PP V > 13% ) accurately identify patients whose ventricles reside on the ascending limb of the Frank-Starling curve and will augment cardiac output following fluid boluses.

  • 4. Microcirculation and the Revised Endothelial Glycocalyx Model
  • The Classical Starling Hypothesis

Ernest Starling (1896) proposed that transvascular fluid filtration ( J v J_v J v ​ ) was governed by the net balance between hydrostatic and colloid oncotic pressure gradients across the semipermeable capillary endothelium:

J v = K f ⋅ [ ( P c − P i f ) − σ ( π c − π i f ) ] J_v = K_f \cdot [(P_c - P_{if}) - \sigma (\pi_c - \pi_{if})] J v ​ = K f ​ ⋅ [( P c ​ − P i f ​ ) − σ ( π c ​ − π i f ​ )]

Where K f K_f K f ​ is capillary filtration coefficient, P c P_c P c ​ is capillary hydrostatic pressure, P i f P_{if} P i f ​ is interstitial hydrostatic pressure, σ \sigma σ is the reflection coefficient for albumin ( 0 ≤ σ ≤ 1 0 \le \sigma \le 1 0 ≤ σ ≤ 1 ), π c \pi_c π c ​ is plasma colloid oncotic pressure, and π i f \pi_{if} π i f ​ is interstitial oncotic pressure.

Classical Model Prediction: Net fluid filtration occurred at the arterial end of the capillary ( P c > π c P_c > \pi_c P c ​ > π c ​ ), and net fluid reabsorption occurred at the venular end ( P c < π c P_c < \pi_c P c ​ < π c ​ ). REVISED ENDOTHELIAL GLYCOCALYX MODEL:

  • =================== ENDOTHELIAL CELL ===================
  • [ Luminal Blood ] ---> Endothelial Glycocalyx Layer (EGL)
  • | (Semipermeable molecular sieve)
  • [ Subglycocalyx Space ] -+ (Very low protein: pi_sg ~ 0)
  • =================== INTERCELLULAR CLEFT ================
  • [ Interstitial Space ] (pi_if does NOT drive reabsorption!)
  • -------------------------------------------------------

* Hydrostatic gradient (Pc - Pif) favors outward filtration throughout.

* Oncotic gradient opposes filtration via (pi_c - pi_sg).

* NO STEADY-STATE REABSORPTION AT VENULAR END!

* All filtered fluid returned exclusively via LYMPHATICS.

The Revised Endothelial Glycocalyx Model (Levick and Michel)

Modern ultrastructural research demonstrated that the primary semipermeable oncotic barrier is not the endothelial cell junction, but the Endothelial Glycocalyx Layer (EGL) —a web of membrane-bound proteoglycans (syndecans, glypicans), glycosaminoglycans (heparan sulfate, chondroitin sulfate), and adsorbed plasma albumin lining the luminal surface.

The Subglycocalyx Space: Beneath the glycocalyx and inside the intercellular cleft lies the subglycocalyx space. Fluid filtration constantly flushes proteins outward through the wide inter-endothelial clefts; consequently, the oncotic pressure in the subglycocalyx space ( π s g \pi_{sg} π s g ​ ) is extremely low (near zero) .

The Revised Equation: J v = K f ⋅ [ ( P c − P i f ) − σ ( π c − π s g ) ] J_v = K_f \cdot [(P_c - P_{if}) - \sigma (\pi_c - \pi_{sg})] J v ​ = K f ​ ⋅ [( P c ​ − P i f ​ ) − σ ( π c ​ − π s g ​ )]

The "No Reabsorption" Rule: Because the subglycocalyx space is virtually devoid of protein, the effective opposing oncotic pressure gradient is π c − π s g \pi_c - \pi_{sg} π c ​ − π s g ​ , which is much higher than π c − π i f \pi_c - \pi_{if} π c ​ − π i f ​ . Even at the venular end of the capillary (where P c P_c P c ​ drops to 15 mmHg 15\text{ mmHg} 15 mmHg ), P c P_c P c ​ still exceeds the true opposing transvascular oncotic force. Consequently, there is NO steady-state venous fluid reabsorption in continuous capillaries (skin, muscle, lung, connective tissue). Filtration continues along the entire length of the capillary (decreasing in magnitude, but never reversing).

Role of Lymphatics: 100 % 100\% 100% of all filtered interstitial fluid and extravasated plasma proteins are returned to the vascular system exclusively via the lymphatic system .

Glycocalyx Pathology in Anaesthesia: Sepsis, ischemia-reperfusion injury, hyperglycemia, and hypervolemia (via Atrial Natriuretic Peptide release) degrade the glycocalyx. Destruction of the glycocalyx abolishes σ \sigma σ , precipitating massive transudation of fluid and albumin into the interstitial space (interstitial edema and third-spacing).

  • 5. Autoregulation Mechanisms and Vasomotor Reflexes
  • Vascular Autoregulation

Autoregulation is the intrinsic ability of vital vascular beds to maintain relatively constant blood flow despite wide variations in perfusion pressure:

Cerebral Circulation: Constant between M A P = 50 − 150 mmHg MAP = 50-150\text{ mmHg} M A P = 50 − 150 mmHg .

Renal Circulation: Constant between M A P = 80 − 180 mmHg MAP = 80-180\text{ mmHg} M A P = 80 − 180 mmHg .

Coronary Circulation: Constant between perfusion pressures of 60 − 140 mmHg 60-140\text{ mmHg} 60 − 140 mmHg .

Three Core Mechanisms of Autoregulation

Myogenic Mechanism (Bayliss Effect): Intrinsic smooth muscle response. Acute elevations in intravascular transmural pressure stretch vascular smooth muscle cells in small arterioles, activating stretch-sensitive non-selective cation channels. The resulting depolarization opens voltage-gated L-type calcium channels, triggering rapid vasoconstriction. When pressure falls, reduced stretch produces relaxation.

Metabolic Mechanism: Increased tissue metabolic activity or reduced blood flow causes local accumulation of vasodilatory metabolites: adenosine, H + \text{H}^+ H + , lactate, K + \text{K}^+ K + , interstitial hyperosmolarity, and CO 2 \text{CO}_2 CO 2 ​ , combined with local hypoxia. These metabolites relax arteriolar sphincters, restoring flow.

Endothelial Mediators: Endothelial cells release vasoactive factors in response to flow shear stress and receptor activation:

Vasodilators: Nitric Oxide (NO; activates soluble guanylyl cyclase → ↑ \rightarrow \uparrow →↑ cGMP) and Prostacyclin ( P G I 2 PGI_2 PG I 2 ​ ; activates adenylyl cyclase → ↑ \rightarrow \uparrow →↑ cAMP).

Vasoconstrictors: Endothelin-1 (ET-1; acts on E T A ET_A E T A ​ receptors on vascular smooth muscle).

Cardiovascular Autonomic Reflexes

Reflex Sensor & Afferent Pathway Efferent Limb Physiological Trigger & Hemodynamic Response

Arterial Baroreceptor Reflex Mechanoreceptors in carotid sinus (CN IX, sinus nerve of Hering) and aortic arch (CN X). Afferents project to the nucleus tractus solitarius (NTS) in the medulla. NTS excites caudal ventrolateral medulla (CVLM) → \rightarrow → inhibits RVLM (sympathetic outflow); NTS excites nucleus ambiguus (parasympathetic outflow). High BP: ↑ \uparrow ↑ firing → \rightarrow → bradycardia, reduced inotropy, and peripheral vasodilation. Low BP: ↓ \downarrow ↓ firing → \rightarrow → sympathetic activation (tachycardia, vasoconstriction). Operates dynamically between 60 and 180 mmHg 60\text{ and }180\text{ mmHg} 60 and 180 mmHg .

Bainbridge Reflex Stretch mechanoreceptors located at the venoatrial junctions and right atrial wall. Afferents travel via the vagus nerve (CN X). Efferent sympathetic discharge to the sinoatrial node. Sudden Volume Infusion / Atrial Stretch: Triggers reflex tachycardia to accelerate venous emptying and prevent venous congestion. Antagonizes baroreceptor bradycardia during rapid volume loading.

Bezold-Jarisch Reflex Mechanosensitive and chemosensitive unmyelinated C-fibers located in the inferoposterior wall of the left ventricle. Afferents travel via the vagus nerve (CN X). Massive vagal parasympathetic outflow accompanied by sympathetic inhibition. The Triad: Bradycardia, Peripheral Vasodilation, and Severe Hypotension. Triggered by chemical irritants, severe inferior wall myocardial ischemia, or extreme hypovolemia in an underfilled, vigorously contracting ventricle (e.g. spinal anaesthesia or beach-chair position).